Treatment deviation in patients initiated on rosuvastatin 5 mg and simvastatin 20 mg, respectively

Type of first deviation from initial treatment during follow-up *	Total		Men		Women
	Rosuvastatin 5 mg	Simvastatin 20 mg	Rosuvastatin 5 mg	Simvastatin 20 mg	Rosuvastatin 5 mg	Simvastatin 20 mg
	n (%)	n (%)	n (%)	n (%)	n (%)	n (%)
Change to another dose of the initial statin	7284	4825	3474	2129	3810	2696
	(6.8)	(8.5)	(7.5)	(8.5)	(6.3)	(8.5)
Switch to another statin	6101	4962	2631	2214	3470	2748
	(5.7)	(8.7)	(5.7)	(8.8)	(5.7)	(8.7)
Temporary discontinuation for more than 6 months †	7825	4107	3241	1747	4584	2360
	(7.3)	(7.2)	(7.0)	(6.9)	(7.6)	(7.5)
Permanent discontinuation not preceded by switches or temporary discontinuation ‡	20 409	10 303	8324	4256	12 085	6047
	(19.1)	(18.1)	(18.0)	(16.9)	(19.9)	(19.1)
All types	34 335	19 372	14 196	8217	20 139	11 155
	(38.9)	(42.5)	(38.2)	(41.0)	(39.5)	(43.8)

^*Between the end of the 1-year selection period with regular prescriptions for the initial treatment and the end of the study period.

^†Followed by a new prescription for statin (i.e., an interval of more than 6 months between two consecutive prescriptions).

^‡Before the end of the study period (i.e., with an interval of more than one month between (1) the month at which the last prescription for the initial treatment should have ended and (2) the end of the study period).